National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

therapeutic epinephrine
The synthetic form of the naturally occurring sympathomimetic amine with vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. By stimulating vascular alpha-adrenergic receptors, epinephrine causes vasoconstriction, thereby increasing vascular resistance and blood pressure. When administered in the conjunctiva, this agent binds to alpha-adrenergic receptors in the iris sphincter muscle, resulting in vasoconstriction, a decrease in the production of aqueous humor, and a lowering of intraocular pressure. Through its beta1 receptor-stimulating actions, epinephrine increases the force and rate of myocardial contraction and relaxes bronchial smooth muscle, resulting in bronchodilation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:adrenaline
epinephrine
Abbreviation:epi



Previous:therapeutic allogeneic lymphocytes, therapeutic angiotensin-(1-7), therapeutic autologous dendritic cells, therapeutic autologous lymphocytes, therapeutic dehydroepiandrosterone
Next:therapeutic estetrol, therapeutic estradiol, therapeutic hemin, therapeutic hydrocortisone, therapeutic immune globulin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov